Aim Immunotech Incis A Biotechnology Company Based In Ocalafloridafocused On Developing Therapeutics For Various Cancersviral Diseasesand Immune Deficiency Disordersestablished In 1966The Company Was Formerly Known As Hemispherx Biopharma Incand Rebranded In August 2019Aim Immunotech Is Dedicated To Research And Developmentparticularly In Immune Modulation Therapiesand Actively Participates In Clinical Trials And Research Programs The Companyae S Lead Productampligenrintatolimod Is An Immuno Modulator Approved In Argentina For Severe Chronic Fatigue Syndrome And Is Under Evaluation For Several Cancers And Covid 19 Related Conditionsanother Productalferon N Injectionis Used To Treat Human Papilloma Viruses And Genital Wartsaim Immunotech Collaborates With Various Research Institutions And Companies To Enhance Its Therapeutic Offeringsserving Healthcare Providers And Research Entities In The Medical Field
